| 121 | fercit | | 14/10/2021 11:02:14 | |
| 122 | Resposible conduct of research | | 14/10/2021 11:55:59 | |
| 123 | Good Clinical Practice | | 14/10/2021 13:28:48 | |
| 124 | CITI program | | 14/10/2021 14:53:28 | |
| 125 | 2 | | 14/10/2021 16:16:06 | |
| 126 | 3 | | 14/10/2021 16:16:30 | |
| 127 | 1 | | 14/10/2021 16:16:51 | |
| 128 | 4 | | 14/10/2021 16:17:09 | |
| 129 | 5 | | 14/10/2021 16:17:23 | |
| 130 | 6 | | 14/10/2021 16:17:33 | |
| 131 | 7 | | 14/10/2021 16:17:44 | |
| 132 | 8 | | 14/10/2021 16:17:59 | |
| 133 | จริยธรรมการวิจัยในคน2019 | | 14/10/2021 16:18:33 | |
| 134 | GCP (U.S. FDA Focus) for IRB members, Researchers, Faculty members | | 14/10/2021 16:19:17 | |
| 135 | จริยธรรมการวิจัยในคน2019 | | 14/10/2021 16:19:32 | |
| 136 | Conflicts of Interest for IRB members, Researchers, Faculty members | | 14/10/2021 16:20:33 | |
| 137 | GCP for Clinical Trials with Investigational drugs and Medical devices | | 14/10/2021 16:21:09 | |
| 138 | GCP for Clinical Trials with Investigational drugs and Medical devices | | 14/10/2021 16:21:37 | |
| 139 | Human Subject Protection Course & GCP | | 14/10/2021 23:13:16 | |
| 140 | Conflicts of Interest Ceritificate | | 15/10/2021 07:59:25 | |
